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Abstract: 21 
Background: 22 
Surgical site infection (SSI) is a worldwide problem which has morbidity, mortality and 23 
financial consequences. The incidence rate of SSI is high in Low- and Middle-Income 24 
countries (LMICs) compared to high income countries, and the costly surgical complication 25 
can raise the potential risk of financial catastrophe.  26 
Objective 27 
The aim of the study is to critically appraise studies on the cost of SSI in a range of LMIC 28 
studies and compare these estimates with a reference standard of high income European 29 
studies who have explored similar SSI costs. 30 
Methods  31 
A systematic review was undertaken using searches of two electronic databases, EMBASE 32 
and MEDLINE In-Process & Other Non-Indexed Citations, up to February 2019. Study 33 
characteristics, comparator group, methods and results were extracted by using a standard 34 
template.  35 
Results: 36 
Studies from 15 LMIC and 16 European countries were identified and reviewed in full. The 37 
additional cost of SSI range (presented in 2017 international dollars) was similar in the LMIC 38 
($174 - $29,610) and European countries ($21 - $34,000). Huge study design heterogeneity 39 
was encountered across the two settings.  40 
Discussion: 41 
SSIs were revealed to have a significant cost burden in both LMICs and High Income 42 
Countries in Europe. The magnitude of the costs depends on the SSI definition used, severity 43 
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of SSI, patient population, choice of comparator, hospital setting, and cost items included. 44 
Differences in study design affected the comparability across studies. There is need for 45 
multicentre studies with standardized data collection methods to capture relevant costs and 46 
consequences of the infection across income settings.  47 
Other: 48 
Funding: National Institute of Health Research (NIHR) Global Health Research Unit Grant 49 
(NIHR 17-0799). The funders had no role in study design, data collection and analysis, 50 
decision to publish, or preparation of the manuscript. The views expressed are those of the 51 
authors and not necessarily those of the National Health Service, the NIHR, or the UK 52 
Department of Health and Social Care. 53 
  54 
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Introduction 55 
Mortality within 30 days of surgery is the third largest contributor to global deaths[1]. 56 
Surgical Site Infection (SSI) is linked to 38% of deaths in patients with SSI[2]. SSI is 57 
common, associated with increased patient morbidity and mortality[3, 4] , recognised globally 58 
as a problem and shown to represent a substantial financial burden[5, 6]. In comparison to the 59 
relatively high income countries (HIC) of Western Europe, the incidence rate of SSIs is much 60 
greater in Low- and Middle-Income Countries (LMIC)[7, 8] and here the majority of the 61 
hospital care cost is borne by the patient[9]. In the LMIC setting, the risk of acquiring an SSI 62 
substantially increases the overall risk of financial catastrophe- a situation in which health 63 
care spending on this event exceeds 10% of annual household expenditure[10].  64 
Identifying appropriate solutions to combat SSI is of global interest[6, 11, 12]. Recently 65 
completed and ongoing research studies to find the most cost-effective prevention strategies 66 
for SSI, are having mixed success[13, 14]. The majority of this research is randomised 67 
controlled trials (RCTs) with a parallel economic evaluation based in HIC[15, 16]. Plans are 68 
in place to carry out similar studies exploring cost-effective strategies to combat SSI in the 69 
LMIC setting[17]. Significant challenges hamper clinical trials in LMICs relating to lack of 70 
infrastructure and limited human resources[18]. This limits the data that can be feasibly 71 
collected in contrast to trials in HICs settings.  72 
A cost of illness (COI) study quantifies how much society is spending on a particular disease 73 
and represents the cost burden averted if the disease was eradicated[19]. Understanding the 74 
additional cost burden imposed by the complications of surgery such as those caused by an 75 
SSI, helps to strengthen the case for identifying interventions to reduce such 76 
complications[20]. This in turn provides the justification for undertaking economic 77 
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evaluations to  present relevant evidence to inform the prioritization of resource allocation 78 
decisions for interventions to reduce SSI complications.”.  79 
We identified five main challenges in measuring the additional costs associated with an SSI. 80 
First, different definitions of an SSI affects which patients are considered to have an SSI[21]. 81 
Second, as an SSI can manifest beyond hospital discharge, approaches for post-discharge SSI 82 
confirmation will impact SSI detection rate[22, 23]. Follow-up difficulties can be exacerbated 83 
for surgical patients in low income settings due to high out-of-pocket transportation costs in 84 
accessing healthcare[24]. 85 
Third, estimating the additional cost of SSI relies on the choice of the comparator, which is 86 
patients without SSI. Studies with a case-control design try to address potential confounding 87 
with an adjusted comparison where each of the exposure and control patients have matching 88 
confounding variables (e.g. same age, gender, surgical procedure). Yet, the choice of 89 
matching variables should be considered carefully in case-control studies because of its 90 
impact on the efficiency and validity of the results[25].  91 
Fourth, SSI costs are only as representative as the hospital settings used. Resource use and 92 
costs are known to differ across urban and rural settings and different patient population 93 
mixes from different surgical procedures can influence the cost of SSI, limiting the 94 
generalisability across procedures. Finally, SSIs vary in severity, and those SSIs that are 95 
severe can substantially increase costs and inpatient length of stay[26]. However, the 96 
distinction between SSI severity levels is open to subjective interpretation by the attending 97 
physician[27].  98 
The objective of this study is to critically appraise and assess how the cost of SSI has been 99 
estimated in a range of LMIC studies and compare with a selection of high income European 100 
studies which explored similar SSI costs. European studies are included in the review to 101 
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provide a reference standard for the LMIC studies. The aim of the comparison is to examine 102 
the costs associated with SSI (presented in international dollars) across the different settings 103 
and identify potential data gaps, and methodological considerations in each setting.  104 
This paper is structured so that the review of the selection of European studies is presented in 105 
Part 1. An analogous review of the LMIC studies is presented in Part 2. Part 3 presents a 106 
comparison between the main finding of the reviews for the HIC and LMIC settings before 107 
the main discussion.  108 
Materials and methods 109 
The review followed the UK Centre for Review and Dissemination[28] guidelines and 110 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)[29]. 111 
Search Strategy 112 
The following electronic databases were searched from inception to 20th February 2019: 113 
EMBASE and MEDLINE In-Process & Other Non-Indexed Citations. Additional references 114 
were found using hand searching of relevant journal articles and Google scholar searches. 115 
Search terms used for each database are detailed in S1-S4 Files 116 
Eligibility criteria  117 
Studies were included if they considered the costs associated with SSIs in European 118 
Organisation for Economic Co-operation and Development (OECD) countries[30]. For the 119 
analogous review of LMIC, studies were included if they considered the economic impact of 120 
SSIs in LMICs. For both settings costs could be borne by the healthcare providers, patients, 121 
wider community and/or society. Eligible articles included cost analysis, partial or full 122 
economic evaluations (trial-based and model-based) and cost of illness studies in a European 123 
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country or LMIC setting. Multi-country studies were included if at least one eligible country 124 
was included and the study’s findings were reported separately for that country. Non-eligible 125 
studies were those that were not published in English, conference proceedings, protocols, 126 
commentaries, and editorials.  127 
Study Selection 128 
The titles and abstracts of the databases’ search results were screened against the eligibility 129 
criteria. A three stage categorisation process was used to determine relevant studies 130 
appropriate for inclusion, using methods described elsewhere[31]. Two investigators carried 131 
out study screening and data extraction for the LMIC search (MM & ZA). One investigator 132 
(MM) carried out all study screening and data extraction for the European literature search, 133 
and another investigator (ZA) undertook screening of a random 20% to assess agreement. 134 
Disagreements were resolved through discussion, a third independent investigator (TR) was 135 
sought where agreement could not be reached. 136 
For each included study, data were extracted on the study characteristics, country setting, 137 
costs and resource use included, use of adjusted analyses, and the main results reported. The 138 
information was tabulated, and the issues faced by the individual studies in estimating the 139 
additional costs of SSI were compared narratively. For consistency across studies, costs were 140 
converted to international dollars and inflated to 2017, where appropriate. To improve 141 
comparability of cost findings, costs were adjusted by their country’s Purchasing Power 142 
Parity (PPP) conversion factor[32]. Where a country did not have a PPP conversion factor, an 143 
implied PPP conversion factor from the IMF was used instead[33]. For inflation purposes, 144 
studies without a specified cost year were assumed to be the last year of data collection.  145 
All included studies were assessed by a modified reporting Müller checklist (translated into 146 
English) for COI studies and scored by their inclusion of relevant items[34]. A study scored 147 
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one on each aspect they had described or justified out of a possible maximum score of 36. 148 
The checklist for each study is available upon request. 149 
 150 
Results and Discussion 151 
Part 1: European Literature search  152 
The electronic database search for the European studies yielded 588 citations. Figure 1 153 
presents a flow diagram of the selection process. Sixteen studies met the inclusion criteria. 154 
 155 
 156 
Fig 1. PRISMA diagram of European Search. 157 
 158 
 159 
 160 
General Study Characteristics 161 
The sixteen studies were published from 1992 to 2018 and data collection spanned 1987 to 162 
2016. Studies were based in England (n=6)[35-40],Spain (n=2)[41, 42], Scotland (n=2)[43, 163 
44], Finland (n=1)[45], France (n=1)[46], Switzerland (n=1)[47], Belgium (n=1)[48], 164 
Denmark (n=1)[49] and Germany (n=1)[50]. Table 1 shows general characteristics of each 165 
study included in the review. 166 
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Table 1. European Study characteristics 167 
Lead author 
(Year) 
Country  Patient population Setting Study aim  Type of study  Number of 
SSI & 
Comparator 
Period of data 
collection  
Cardiothoractic surgery 
Graf (2010)[50] Germany CABG patients University 
hospital 
Calculate the costs of deep 
sternal wound infection  
Case-control study 17 SSI/ 34 
Non-SSI  
2006-2008 
Colorectal surgery 
Tanner 
(2009)[37] 
England Adult colorectal 
patients 
University 
hospital 
Provide an accurate cost for 
treating patients with SSI 
Surveillance study 29 SSI/ 76 
Non-SSI 
2008 
Turtiainen 
(2010)[45] 
Finland Vascular surgery 
patients 
Four secondary 
referral hospitals 
Calculate the extra cost of 
services needed to treat SSI 
Prospective 
observational study 
49 SSI /136 
Non-SSI 
2007-2008 
Multiple surgical categories 
Alfonso 
(2007)[41] 
Spain Adult patients General, tertiary 
hospital 
To identify overall costs 
generated by SSI patients 
Cost of illness study 30 SSI/ 52 
non-SSI 
2001-2005 
Defez 
(2008)[46] 
France Acute care patients University 
hospital 
Calculate the additional 
costs of nosocomial 
infection: 
Prospective cohort 
study 
21 SSI/21 
non-SSI 
2001-2003 
Jenks 
(2014)[35] 
England Patients who 
underwent major 
surgical procedures 
University 
hospital 
Determine the clinical and 
economic burden of SSI  
Cost analysis 282 SSI/ 
14,018 non-
SSI 
2010-2012 
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Lead author 
(Year) 
Country  Patient population Setting Study aim  Type of study  Number of 
SSI & 
Comparator 
Period of data 
collection  
Lynch 
(1992)[43] 
Scotland Adult surgical patients Teaching 
hospital 
Study the cost of SSI Cost analysis 513 SSI/ 
2969 non-
SSI 
1987-1989 
Reilly 
(2001)[44] 
Scotland Surgery patients Unspecified 
hospital 
Quantify the cost of SSI to 
the hospital, community, and 
patient 
Prospective cohort 
study 
220 SSI 
/1982 non-
SSI 
1995-1999 
Vegas 
(1993)[42] 
Spain General surgery and 
digestive surgery 
patients 
University 
hospital 
Estimate the length of stay 
of SSI patients 
Prospective cohort 
study 
106 SSI/ 212 
non-SSI 
1990 
Vrijens 
(2012)[48]  
Belgium Acute care patients Acute care 
hospitals in 
Belgium 
Estimate the total economic 
cost of infection to the 
public healthcare provider 
Retrospective cohort 
study 
77 SSI/ 261 
non-SSI 
2007 
Weber 
(2008)[47] 
Switzerland Traumatology, 
visceral and vascular 
surgery patients 
University 
hospital 
Quantify the economic 
burden of SSI 
Retrospective cohort 
study 
168 SSI/ 168 
non-SSI 
2000-2001 
Gynaecological surgery 
Hyldig 
(2018)[49] 
Denmark Obese women after 
caesarean section 
5 obstetric 
departments 
across 2 tertiary 
& 3 teaching 
hospitals 
Evaluate the cost-
effectiveness of incisional 
negative pressure wound 
therapy in preventing SSI 
Within trial cost 
effectiveness 
analysis 
57 SSI/780 
non-SSI 
2013-2016 
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Lead author 
(Year) 
Country  Patient population Setting Study aim  Type of study  Number of 
SSI & 
Comparator 
Period of data 
collection  
Orthopaedic surgery 
Edwards 
(2008)[40] 
England Hip fracture patients University 
hospital 
Estimate the cost of treating 
SSI 
Retrospective cohort 
study 
80 SSI/ 80 
non-SSI 
1999-2004 
Pollard 
(2006)[36] 
England Proximal femoral 
fracture surgery 
patients over 65 years 
Tertiary teaching 
hospital 
Assess the financial burden 
of deep SSI after surgery  
Retrospective cohort 
study 
61 SSI/ 122 
non-SSI 
1998-2003 
Parker 
(2018)[38] 
England Lower limb open 
fracture patients 
24 specialist 
trauma hospitals 
Estimate economic 
outcomes associated with 
deep SSI 
Costing analysis of a 
prospective RCT 
35 SSI/ 423 
non-SSI 
2012-2015 
Thakar 
(2010)[39] 
England Proximal femoral 
fracture patients 
Tertiary teaching 
hospital 
Calculate the additional 
hospital costs due to 
complications  
Prospective cohort 
study 
46 SSI/ 92 
non-SSI 
2003-2008 
All costs were inflated and converted to 2017 international dollars  where appropriate 
NNIS, Nosocomial Infection Surveillance System risk index; SSI, Surgical Site Infection; 
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Definition of SSI 168 
SSI was defined using the Center of Disease Control (CDC) guidelines in most of the 169 
studies[35, 37, 38, 41, 42, 45, 46, 50]. Other strategies for SSI confirmation included using a 170 
microbiological test[36, 39] or if a patient required antibiotic treatment for wound 171 
problems[40, 49]. Lynch et al[43] defined an SSI based on pus discharge or a wound with a 172 
score of greater than ten on ASEPSIS, a scoring mechanism for postoperative SSI[51]. Reilly 173 
et al[44] defined an SSI as pus or painful skin inflammation indicative of cellulitis. 174 
Patients were followed-up for the occurrence of SSI for at least 30 days[35, 41, 43, 44] with 175 
two studies following up SSI patients until the wound had healed[37, 45]. Approaches to 176 
diagnose post-discharge SSI included outpatient clinics or primary care visits[41, 44, 45], 177 
surveys/questionnaires,[35, 43] or a home visit[37].  178 
Patient matching  179 
An imbalance of patient characteristics can bias and confound the cost calculation of SSI 180 
patients. This is analogous to an observational non-RCT setting where the difference in 181 
outcomes may be partially or wholly explained by factors other than the presence of SSI. 182 
Some form of patient matching in the analysis to adjust for confounding variables was used 183 
in most studies[35, 36, 38, 39, 41, 42, 46-48, 50]. However, justification for the selected 184 
matching variables was given in less than half of these studies[36, 38, 39, 41, 48]. 185 
Setting & Procedure 186 
Public teaching hospitals[35-37, 39-43, 46, 47, 50] were the setting for majority of the studies 187 
with one hospital setting unclear[44], and another study referring to unspecified referral 188 
hospitals[45]. Study settings were mostly restricted to a single site with only four studies 189 
involving multiple hospitals[38, 45, 48, 49]. Surgical procedures ranged from general surgery 190 
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or multiple surgery categories (n=8), cardiothoracic (n=1), colorectal (n=2), gynaecological 191 
(n=1), and orthopaedic (n=4).The patient population were all adult patients.  192 
Half the studies that assessed SSI across surgical categories reported surgery category-193 
specific costs associated with SSI [35, 43, 44, 47]. All of these studies showed variation of SSI 194 
costs across surgical categories  Severity of SSI was always associated with increased costs. 195 
A deep SSI was more costly compared to a superficial SSI in all studies that had severity-196 
specific SSI costs[39, 47, 49].  Yet, the stated approaches to classify the superficial versus 197 
deep SSI differed. Approaches to define superficial SSI included CDC criteria[49], or a 198 
treatment for an infection at the surgical site within 30 days postoperatively[47], or were not 199 
defined[39] . Approaches to classify a deep SSI included a microbiological confirmation of 200 
tissue from a further surgery[39],, or an SSI requiring surgery[47] or using  CDC 201 
criteria[49]The sample size of SSI patients in the European studies ranged from as low as 17 202 
patients to as high as 513 patients.  203 
Cost components 204 
The type of costs included and considered in each of the studies is shown in Table 2 and S1 205 
Table. All studies considered at least some form of direct medical costs in their cost 206 
calculations. However, there was a considerable variation in the description and the number 207 
of direct medical cost items included in each study. In terms of the costs arising from the 208 
initial hospitalization of patients, the description of the included cost components ranged 209 
from an unspecified cost per bed day to a comprehensive bottom up costing of the hospital 210 
length of stay, consumables, diagnostics, overhead, reoperation and staffing costs. Non-211 
hospital costs were also considered in some of the studies including post-discharge costs from 212 
general practitioner/ nurse visits[37, 41, 43, 44], and patient/community costs of wound 213 
dressings. 214 
14 
 
Table 2. Costs of SSI in European studies 215 
Lead author 
(Year) 
Adjusted group 
comparison 
Costs included Average cost SSI 
patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Cardiothoractic surgery 
Graf (2010)[50] Age, sex, DRG, 
preoperative LOS 
Surgery, lab tests, 
hospital LOS 
$50,912 $18,751 $32,161 SSI: 34.4 days 
Non-SSI: 16.5 days 
Colorectal surgery 
Tanner 
(2009)[37] 
Unadjusted analysis Hospital stay, nurse & 
GP visits, outpatient 
clinic, wound dressing, 
readmissions, 
antibiotics, wound swab 
Not reported Not reported $18,101 SSI: Extra 22.72 days 
Non-SSI not reported 
Turtiainen 
(2010)[45] 
Unadjusted analysis LOS, Outpatient clinic 
and rehabilitation 
Not reported Not reported $4,237 Not reported 
Multiple surgical categories 
Alfonso 
(2007)[41] 
Age, sex, diagnosis, 
surgery duration, 
comorbidity, and 
procedure 
Hospital Stay, 
readmission, diagnostics, 
antibiotics informal care, 
primary care, 
productivity loss 
Not reported Not reported Health care costs: 
$15,263 
Informal care: 
$15,734 
Societal costs: 
$145,336 
SSI pre-discharge: 
23.73 days 
SSI post-discharge: 
12.99 days 
No SSI: 9.45 days 
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Lead author 
(Year) 
Adjusted group 
comparison 
Costs included Average cost SSI 
patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Defez 
(2008)[46] 
Age, sex, ward type, 
principal diagnosis 
Hospital stay, laboratory 
tests, radiology, surgery, 
diagnostics, & 
antibiotics  
Not reported Not reported $2,780 Not reported 
Jenks (2014)[35] Surgery, age and 
NNIS risk index  
Overhead, staffing costs, 
readmission, 
reoperation, hospital 
stay, diagnostics, 
consumables 
$12,928 $5,837 $5,239 SSI: 19 days  
Non-SSI: 5 days  
Lynch 
(1992)[43] 
Unadjusted 
comparison 
GP visits, wound 
dressings, antibiotic 
costs, hospital stay 
$3,678 $2,116 $1,563 No overall figures 
reported 
Reilly 
(2001)[44] 
Unadjusted 
comparison 
Hospital stay, 
readmissions, GP and 
nurse visits, wound 
dressings, antibiotic 
prescriptions 
Not reported Not reported $541 Not reported 
Vegas 
(1993)[42] 
Diagnosis, procedure, 
age 
Hospital stay Not reported Not reported $10,688 SSI: extra 14.33 days 
Vrijens 
(2012)[48] 
Destination after 
discharge, hospital, 
comorbidity, ward, 
Age, DRG 
Hospital stay Not reported Not reported $3,149 SSI: 35.2 days 
Non-SSI: 29.2 days 
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Lead author 
(Year) 
Adjusted group 
comparison 
Costs included Average cost SSI 
patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Weber 
(2008)[47] 
Age, procedure, and 
NNIS risk 
Antibiotic use, 
postoperative LOS, 
hospital costs and patient 
charges 
Not reported Not reported Overall: $17,060 
Superficial $2,226 
Deep incisional: 
$3,801 
Organ space: 
$34,001 
SSI: 29 days 
Non-SSI: 12.3 days 
Gynaecological surgery 
Hyldig 
(2018)[49] 
Unadjusted analysis Inpatient stays, 
outpatient care, 
antibiotic treatment, 
postoperative dressing, 
primary care visits 
Not reported Not reported Superficial SSI: 
$21 
Deep SSI: $9,527 
Not reported 
Orthopaedic surgery 
Edwards 
(2008)[40] 
Unadjusted analysis Inpatient stay, 
equipment, surgery 
consumables and staff 
salaries, investigations, 
medication, antibiotics 
$49,290 $17,060 $32,229 SSI: 76 days 
Non-SSI not reported 
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Lead author 
(Year) 
Adjusted group 
comparison 
Costs included Average cost SSI 
patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Parker 
(2018)[38] 
Age, sex, trial site, 
wound grade, 
diabetes, height, 
weight, and smoking 
status 
Hospital inpatient & 
outpatient services, 
community health & 
social care, medication, 
aids and adaptations 
$22,255 
(complete case 
analysis) 
$20,429 (complete 
case analysis) 
SSI (multiple 
imputation) 
$2,866  
SSI (complete 
case analysis): 
$1,825 
Not reported 
Pollard 
(2006)[36] 
Sex, age, fracture 
type, ASA grade, pre-
fracture residence 
type, operation, social 
dependency & 
mobility scores 
Hospital stay, 
Antibiotics, outpatient 
treatment, theatre time, 
prosthetic costs, 
radiology, physiotherapy 
$44,157 $13,043 $31,114 SSI: 80 days (median) 
Non-SSI: 28 days 
(median) 
Thakar 
(2010)[39] 
Sex, age, fracture 
type, ASA grade, 
operation, pre-
fracture residence 
type, social 
dependency & 
mobility 
Theatre time, prosthetic 
costs, radiology and 
pharmaceuticals 
Superficial SSI: 
$30,193 
Deep SSI: 
$39,299 
Superficial SSI 
control: $13,987 
Deep SSI control: 
$13,631 
Superficial SSI: 
$16,206 
Deep SSI: 
$25,669 
Superficial SSI: 62.5 
days 
Superficial SSI 
control: 35 days 
Deep SSI: 79.3 days 
Deep SSI matched 
control: 34.3 days 
All costs were inflated and converted to 2017 international dollars where appropriate. 
ASA grade, American Society of Anaesthesiologists; DRG, Diagnosis-related group; GP, General Practitioner; HAI, Hospital Acquired Infection; LOS, 
Length of stay; NNIS, Nosocomial Infection Surveillance System risk index; SSI, Surgical Site Infection 
 216 
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To facilitate a cost comparison across studies a specified year for which the costs are 217 
applicable allows for the findings to be inflated correctly. The cost year was not stated in six 218 
studies[35, 40, 43, 45, 46, 50]. Transparency on the amount that each cost component is 219 
contributing to the additional cost of SSI clarifies which aspects of medical care are driving 220 
the additional cost burden. However, the additional cost of SSI was not broken down into 221 
their cost components in seven studies[36, 38, 42, 45, 47, 49].  222 
All but one study restricted costs to the perspective of the health care payer. Alfonso et al[41] 223 
widened the perspective to societal and looked at direct and indirect costs associated with SSI 224 
including hospital, primary care, informal care, and productivity loss. 225 
Resource use 226 
The reporting of resource use of SSI and non-SSI patients was inconsistent across studies. 227 
Beyond the main resource item of hospital length of stay, there was little detail on the 228 
differential resource use of SSI and non-SSI patients. Alfonso et al [41] (Spain) reported that 229 
patients with an SSI had significantly longer durations of use for hospital consumables 230 
(catheters, and antibiotics) compared with patients without an SSI. However, resource use 231 
details were omitted on general practitioner/ nurse visits and the level of informal care 232 
needed. Reilly et al[44] (UK) presented a breakdown of resource use for SSI patients only. 233 
Cost of Surgical Site Infection  234 
Overall there was a lack of detail in the reporting of costs for SSI and non-SSI patients. 235 
Average costs of both the respective SSI and non-SSI patients groups were omitted for the 236 
majority of studies[37, 41, 42, 44-49].  237 
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Lynch et al[43] had the lowest relative magnitude of cost difference with SSI costs being 1.73 238 
times higher than non-SSI costs. The authors had estimated the costs of SSI and non-SSI 239 
patients as $3,678 and $2,116 respectively[43].  240 
Pollard et al[36] reported the highest relative magnitude of cost difference with SSI costs 241 
being 3.39 times higher than non-SSI costs. For elderly proximal femoral fracture surgery 242 
patients, they had estimated the costs of SSI and non-SSI patients to be $44,157 and $13,043 243 
respectively. Their inclusion criteria meant that the SSI patients were those who specifically 244 
needed further surgery, representing an upper estimate of the additional costs of an SSI. 245 
While all eligible studies had to present a cost difference between SSI and non-SSI patients, 246 
there was a lack of reporting of the average costs for the SSI and non-SSI patient groups used 247 
to calculate the difference (Table 2). All studies showed an elevated cost of SSI relative to 248 
non-SSI patients. The additional medical costs of SSI, which included costs incurred by the 249 
hospital and health system, ranged from $21 to $34,001 per patient. 250 
The lowest additional cost associated of SSI was estimated in a Danish study assessing the 251 
cost-effectiveness of incisional negative pressure wound therapy in obese women after 252 
caesarean section. In addition to the cost-effectiveness results, the study also provided a per-253 
patient cost of superficial SSI and deep SSI compared with patients who did not suffer an 254 
SSI. The superficial SSI was defined as requiring antibiotic treatment for an infection at the 255 
surgical site within the first 30 days after the caesarean section and not requiring further 256 
surgery.The highest additional health care cost associated with SSI was estimated by Weber 257 
et al[47]. While the average additional cost of all SSI patients was $17,060, an organ space 258 
SSI approximately doubled the additional cost of an SSI in their case-control designed study.  259 
Alfonso et al[41] (Spain) was the only study to adopt a broader societal perspective and 260 
included the cost of productivity loss, informal care and health care costs. They estimated the 261 
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cost associated with SSI to be an additional $145,366 per patient. This estimate comprised 262 
productivity costs (78.7%) with carer costs (10.8%) and health costs (10.5%) making up the 263 
remainder. Including only the health care costs made the additional cost of SSI $15,733 per 264 
patient.  265 
Checklist 266 
All studies were compared against a modified reporting Müller COI study checklist (see 267 
Table S1 for scores). Alfonso et al[41, 52] achieved the highest number of items (23 points) 268 
in the checklist with detailed descriptions of the methods used to estimate the additional costs 269 
of SSI. Turtainen et al[45] achieved the lowest score (11 points) in the checklist with little to 270 
no description in the study on what was included in the SSI cost estimate and how it was 271 
derived. In general, studies scored relatively poorly in the evaluation methods and 272 
presentation of results section of the checklist but highly in the discussion and conclusions 273 
sections.  274 
PART 2: LMIC LITERATURE SEARCH  275 
The LMIC studies electronic database search yielded 2,557 citations. Five additional records 276 
were identified through hand searching references of included papers. Figure 2 presents a 277 
flow diagram of the selection process. Fifteen studies met the inclusion criteria. 278 
  279 
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 280 
Fig 2. PRISMA Diagram of LMIC search. 281 
General Study Characteristics 282 
The fifteen studies were published from 2003 to 2018 and data collection spanned 1999 to 283 
2015. Studies were based in Turkey (n=3)[53-55], China (n=2)[56, 57], Jordan (n=2)[58, 59], 284 
Thailand (n=2)[60, 61], Brazil (n=1)[62], Egypt (n=1)[63], India (n=1)[64], Mexico 285 
(n=1)[65],Rwanda (n=1)[66], and South Africa (n=1)[67]. According to the World Bank 286 
classifications, the studies were part of the following income groups: Low Income Country 287 
(n=1) [66], Lower Middle Income (n=2)[63, 64] and Upper Middle Income (n=12)[53-62, 65, 288 
67]. Table 3 shows general characteristics of each study included in the review.289 
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Table 3. LMIC Study characteristics 290 
Lead author 
(Year) 
[Income Group] 
Country  Patient population Setting Study aim  Type of study  Number of SSI 
& Comparator 
Period of 
data 
collection  
Cardio-thoracic surgery 
Al-Zaru 
(2011)[58] 
[Upper Middle 
Income] 
Jordan  CABG adult patients Teaching hospital Assess clinical & 
economic impact 
of SSIs  
Retrospective 
comparative study, cost 
estimation  
106 SSI/  
525 Non-SSI 
2005-2008  
Coskun 
(2005)[55] 
[Upper Middle 
Income] 
Turkey CABG adult patients 
referred back with Sternal 
SSI 
Private hospital Evaluate costs & 
outcomes for 
Sternal SSI  
Prospective 
surveillance  
88 SSI/ 
88 Non-SSI 
1999-2002 
General Surgery or multiple surgical categories 
Dramowski 
(2016)[67] 
[Upper Middle 
Income] 
South 
Africa  
Paediatric surgery, 
orthopaedics and urology 
patients  
Teaching 
Children hospital  
Investigate burden 
& risk factors of 
HAI  
Prospective 
surveillance  
21 SSI/  
1022 Non-SSI  
2014 -2015 
Galal (2011)[63] 
[Lower Middle 
Income] 
Egypt  Surgery patients 21-60 
years  
Teaching hospital Compare different 
sutures for SSI 
reduction 
Prospective randomised 
double blind study  
50 SSI/ 
400 Non-SSI 
Not reported 
Porras-Hernández 
(2003)[65] 
[Upper Middle 
Income] 
Mexico  Neurological, 
cardiovascular & general 
surgery patients, younger 
than 18 years 
Tertiary teaching 
paediatric 
hospital 
Determine the 
incidence of SSI 
Prospective study  80 SSI /  
348 Non-SSI 
1998-1999 
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Lead author 
(Year) 
[Income Group] 
Country  Patient population Setting Study aim  Type of study  Number of SSI 
& Comparator 
Period of 
data 
collection  
Siribumrungwong 
(2015)[61] 
[Upper Middle 
Income] 
Thailand Varicose Vein patients Teaching hospital Economic 
evaluation of 
interventions for 
great saphenous 
vein ablation 
Prospective cohort 
study / economic 
analysis  
4 SSI/ 73 Non-
SSI 
2011-2013 
Tiwari (2013)[64] 
[Lower Middle 
Income] 
India  Adult patients with at least 
48 hours hospital stay 
Private tertiary 
care hospital 
Assess the costs 
associated with 
HAIs 
Retrospective 
comparative study / 
cost analysis  
4 SSI/ 104 Non-
SSI 
2008-2009 
Gastrointestinal surgery 
Liu (2018)[57] 
[Upper Middle 
Income] 
China Colorectal cancer adult 
patients who had tumour 
surgically removed  
Tertiary public 
hospital 
Economic burden 
caused by HAIs 
Retrospective 
surveillance / cost 
analysis 
20 SSIs/ 38 Non-
SSI 
2015 
Özmen 
(2016)[53] 
[Upper Middle 
Income] 
Turkey  Elective gastric surgery 
cancer patients 
Teaching hospital Factors affecting 
SSI rate after 
elective gastric 
cancer surgery 
Prospective 
observational cohort 
study  
10 SSI/ 42 Non-
SSI  
2013 
Phothong 
(2015)[60] 
[Upper Middle 
Income] 
Thailand Patients with sigmoid 
cancer  
Teaching hospital Outcomes and 
treatment costs 
following a 
sigmoidectomy 
Retrospective review / 
Economic analysis  
6 SSI/ 44 Non-
SSI 
2008-2013 
Silverstein 
(2016)[66] 
[Low Income] 
Rwanda  Biliary disease surgery 
patients 
Referral military 
hospital, 
secondary and 
tertiary care 
Laparoscopic 
cholecystectomy 
versus an open 
approach  
Economic analysis / 
Cohort study 
Not reported  Not reported  
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Lead author 
(Year) 
[Income Group] 
Country  Patient population Setting Study aim  Type of study  Number of SSI 
& Comparator 
Period of 
data 
collection  
Gynaecological Surgery 
Köşüş (2009)[54] 
[Upper Middle 
Income] 
Turkey Women who had caesarean 
surgery  
Private hospital  Trial on the 
prevention of post-
caesarean wound 
infection 
Randomised 
prospective study  
38 SSI/ 76 Non-
SSI 
2004-2007 
Cardio & Neurological surgery 
Zhou (2015)[56] 
[Upper Middle 
Income]  
China  Patients who had a 
craniocerebral operation  
Tertiary care 
hospital 
Cost-benefit 
analysis of SSI 
control 
Prospective study / 
economic analysis  
12 SSI/ 588 Non-
SSI  
2009-2012 
Hweidi 
(2018)[59] 
[Upper Middle 
Income] 
Jordan Adult patients who had a 
craniocerebral operation 
Teaching hospital Estimate the 
additional 
healthcare costs 
attributable to SSI 
Retrospective case 
control study 
32 SSI/ 32 Non-
SSI 
2009- 2015 
Orthopaedic surgery 
Dal-paz 
(2010)[62] 
[Upper Middle 
Income] 
Brazil Total knee arthroplasty 
patients 
Tertiary level 
teaching hospital  
Estimate the 
additional cost of 
nosocomial 
infections  
Retrospective 
observational cohort 
study / cost analysis  
34 SSI/  
Non-SSI cases not 
reported 
2006-2007 
All costs were inflated and converted to 2017 international dollars where appropriate 
CABG, Coronary Artery Bypass Graft; HAI, Hospital Acquired Infection; SSI, Surgical Site Infection; 
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 292 
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Definition of SSI 293 
The Center of Disease Control guidelines were used in the majority of the studies to define an 294 
SSI[53-58, 62-65, 67]. However, three studies lacked a definition of what constituted a 295 
SSI[60, 61, 66]. One study classified a SSI based on the wound discharge culture or other SSI 296 
suggestive signs and symptoms but these were not elaborated further[59].  297 
Post-discharge SSIs cannot be detected where there is no follow-up. In this review, patients 298 
were not followed up after hospital discharge or it was not indicated in many of the 299 
studies[56, 57, 59-62, 64, 66, 67]. Where follow-up was specified, it was only recorded if the 300 
patient happened to return to the index hospital in two studies[55, 58]. The only specified 301 
method of follow-up in the studies was attendance of an outpatient clinic attendance a month 302 
after the patient’s operation[53, 55, 63, 65].  303 
Patient matching 304 
When estimating the additional cost burden of SSI, most of the studies did not make any 305 
adjustments in the comparison with non-SSI patients or it was unclear if adjustment had been 306 
used (Table 3). Justification on the inclusion of the patient matching variables was only given 307 
in one of the six studies where patient matching was utilised[57]. 308 
 309 
Setting & Procedure 310 
The setting where the findings are derived from were mainly public teaching hospitals[41, 53, 311 
58-63, 65, 67] with three based in private hospitals[54-56, 64]. All the studies were based in 312 
single centres. Surgical procedures ranged from general surgery or multiple surgical 313 
categories (n=5), oncological procedures (n=4), cardiothoracic (n=2), orthopaedic (n=1), 314 
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gastric (n=1), general, cardiac and neurosurgery (n=2).The patient population was broader in 315 
the LMIC studies and varied from children (n=2), adults (n=12) and pregnant women (n=1). 316 
For the studies with SSI patients taken from multiple surgical categories, none reported costs 317 
of SSI by surgical category. 318 
SSI severity increased the additional cost of SSI[55, 57]. A subgroup analysis of one study 319 
had low sample sizes for the superficial (n=13), subcutaneous (n=6) and deep soft SSIs 320 
(n=1)53. Another study compared the severity of infections in three different types of surgical 321 
procedure, however, the reported cost was for all cases[65]. 322 
In general, studies tended to have a low number of SSI patients with the sample size of SSI 323 
patients in each study ranging from 4 patients[61, 64] to 106 patients[58]. Six studies had 324 
twenty or fewer SSI patients[53, 54, 57, 60, 61, 64].  325 
Cost components 326 
All studies estimated direct medical costs (Table 4). The lack of follow-up of patients beyond 327 
discharge limited most of the studies to report only inpatient hospital costs. One study had 328 
attempted to measure the direct non-medical costs, however the authors did not report it as a 329 
cost of an SSI[66]. Most studies did not report the relevant year for the cost estimation (S2 330 
Table). The majority of studies did not break down the extent to which each cost component 331 
makes up the costs of SSI and non-SSI patients. Where cost components were reported in 332 
studies, it either included both SSI and non-SSI patients[56, 60, 64] or was limited to only 333 
SSI patients[54, 55, 62]. 334 
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Table 4. Costs of SSI in LMIC studies 335 
Lead author (Year) Adjusted group 
comparison 
Costs included Average cost 
SSI patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Cardio-thoracic surgery 
Al-Zaru (2011)[58] Unadjusted 
comparison 
Hospital stay, 
medications, 
radiology, 
microbiological & lab 
tests 
$31,666 $22,329 $9,337 SSI: 16.7 days  
Non-SSI: 7.8 days  
Coskun (2005)[55] Age & sex Medication, 
examination and lab 
test, hospital stay, 
additional operation 
Not reported  Not reported  Deep: $23,408 
Superficial: 
$12,782 
Deep SSI: Extra 35 
days  
Superficial SSI: Extra 
21 days  
General surgery 
Dramowski 
(2016)[67] 
Age, ward, 
preoperative length 
of stay 
Hospital length of 
stay,  laboratory 
investigations, 
radiology and 
pharmacy cost 
Not reported  Not reported  $1,546 SSI median excess 
days: 4 days  
Non-SSI: not reported 
Galal (2011)[63] Unadjusted 
comparison 
Hospital stay $2,465 $610 $1,855 SSI: 7.10 days 
Non-SSI: 3.39 days 
Porras-Hernández 
(2003)[65] 
Unadjusted 
comparison 
Hospital stay 
(excluding antibiotics) 
Not reported  Not reported  $2,164 SSI: 13 days 
Non-SSI: 6 days 
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Lead author (Year) Adjusted group 
comparison 
Costs included Average cost 
SSI patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Siribumrungwong 
(2015)[61] 
Not reported Unspecified hospital 
costs  
Not reported  Not reported  $174 Not reported 
Tiwari (2013)[64] Matched groups of 
HAI and non-HAI 
by age, diagnosis, 
illness severity 
Consumables, hospital 
room, medications, 
investigations, blood 
components, 
consultation 
$37,295 $7,685 $29,610 SSI: Not reported 
Non-SSI: 9 days 
Gastrointestinal surgery 
Liu (2018)[57] Age, sex, 
comorbidity, disease, 
and prior surgeries  
Medication, 
equipment & supplies, 
diagnostics  
Not reported  $11,691 Overall: $1,410 
Superficial: $462 
Subcutaneous SSI: 
$2,386 
Deep soft SSI: 
$17,094 
SSI: Not reported 
Non-SSI: 22 days 
(median) 
Özmen (2016)[53] Unadjusted 
comparison 
Hospital stay $4,195 $4,872 SSI patients had 
lower costs 
SSI: 5.27 days 
Non-SSI: 5.40 days  
Phothong (2015)[60] Unadjusted 
comparison 
Room charges, theatre 
time, medication, 
anaesthesia, 
equipment & 
laboratory charges & 
nursing 
$12,109 $5,960 $6,149 SSI: 23.5 days 
Non-SSI: 9.8 days 
Silverstein (2016)[66] Not reported Unclear Not reported Not reported $483 Not reported 
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Lead author (Year) Adjusted group 
comparison 
Costs included Average cost 
SSI patients 
Average costs 
Non-SSI patients 
Additional cost of 
SSI 
Length of Stay 
Cardio & Neurological surgery 
Zhou (2015)[56]  Age, sex, operation 
type, incision type, 
operation date, & 
physical status  
Medication, 
equipment, lab test, 
treatment, exams and 
additional surgeries 
$16,979  $10,240  $6,739 SSI: 29 days 
Non-SSI: 17.25 days  
Hweidi (2018)[59] Age, sex, index 
diagnosis, admission 
month 
Length of stay, 
antibiotics, reoperation 
$34,872 $15,974 $18,899 SSI: 30.15 days 
Non-SSI: 6.98 days 
Gynaecological surgery 
Köşüş (2009)[54] Unadjusted 
comparison 
Preventative 
antibiotics, hospital 
readmission and out-
patient  
$1,736 $0 $1,736 Two SSI patients had 
7 days readmission. 
None for Non-SSI 
patients 
Orthopaedic surgery 
Dal-paz (2010)[62] Unadjusted 
comparison 
Hospital stay, lab and 
imagining test, 
additional operations 
and antibiotics 
Not reported  Not reported  $3,865 SSI: Extra 29.7 days 
Non-SSI not reported 
All costs were inflated and converted to 2017 international dollars where appropriate.  
CABG, Coronary Artery Bypass Graft; HAI, Hospital Acquired Infection; SSI, Surgical Site Infection; 
 336 
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Resource use 337 
There was no reporting of resource use of SSI and non-SSI patients beyond hospital length of 338 
stay in any of the studies. There was partial reporting on the additional procedures or 339 
investigations for SSI[55, 62] but no detail on the total resource use by SSI and non-SSI 340 
patients.  341 
Cost of Surgical Site Infection  342 
The additional cost of SSI varied considerably across the studies. All but one study showed 343 
an elevated cost of SSI relative to non-SSI patients. The study by Özmen et al[53] (Turkey) 344 
study looked at outcomes of patients after elective gastric cancer surgery and found that the 345 
unspecified hospital costs were non-significantly lower for superficial SSI patients compared 346 
to non-SSI patients. The calculations behind the lower SSI cost was unclear given that overall 347 
hospital costs were higher than either of the mean costs of the patient groups (SSI and non-348 
SSI). 349 
The additional cost of SSI ranged from $174 (Thailand)[61] to $29,610 (India)[64]. The 350 
lowest additional cost of SSI was from a study by Siribumrungwong et al[61]. Their SSI cost 351 
was made up of undefined hospital costs of four SSI patients with no detail of the non-SSI 352 
comparator group. The highest additional cost of SSI was from a study by Tiwari et al[64]. 353 
For their four patients who suffered an SSI, drug acquisition costs, length of stay and 354 
antimicrobial drugs were the main cost drivers.  355 
Clarity on the relative magnitude of difference in cost between SSI and non-SSI patients was 356 
mixed. Half of studies did not present average costs of both SSI and non-SSI patients. The 357 
lowest relative magnitude of difference in reported costs was in Jordan where SSI costs were 358 
1.4 times higher than non-SSI costs[58]. However, it is unclear what cost items are the major 359 
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contributors of the additional costs. They had estimated the costs of SSI and non-SSI patients 360 
as $31,666 and $22,329, respectively. The highest relative magnitude of difference in costs 361 
was in India where Tiwari et al[64] found that SSI costs were 4.8 times higher than non-SSI 362 
costs[64]. The authors had estimated the costs of SSI and non-SSI patients as $37,295 and 363 
$7,685 respectively.  364 
Checklist 365 
For the COI checklist, the studies achieved on average a score of 11.07 out a maximum of 366 
possible score of 36. The lack of a stated perspective and cost year reduced the scores of 367 
many of the LMIC studies. Dramowski et al[67] scored the highest number of items (16) in 368 
the discussion and conclusion. The lack of description of pertinent study items meant that 369 
Porras-Hernández et al[65] scored the lowest (6).  370 
Part 3: Comparison between HIC European Countries 371 
and LMICs 372 
The CDC criteria were used for SSI diagnosis by most studies in both settings. The biggest 373 
methodological difference between the HIC and LMIC settings was the use of adjusted 374 
analyses for comparing SSI and non-SSI patients. Most European studies used patient 375 
matching while the opposite was true for LMIC studies. Multicentre study settings were only 376 
present in the European studies. Slightly more European studies had follow up beyond 377 
discharge but the follow-up methods varied. Sample sizes of SSI patients tended to be higher 378 
in the European studies. On the other hand, LMIC studies had marginally better reporting of 379 
the average costs of the SSI and non-SSI patient groups. 380 
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For the COI reporting checklist, the European studies achieved a higher score on average 381 
compared with the LMIC studies. In both settings, studies tended to score highly in the 382 
discussion and conclusion checklist but poorly on the evaluation methods and result 383 
presentation sections. 384 
Statement of principal findings 385 
This review assessed the estimated the cost burden of SSIs in the reported literature for both 386 
LMICs and a selection of European High Income Countries.  387 
For medical costs, the additional cost of SSI was $21 to $34,000 in European studies while 388 
the additional cost attributed to SSI ranged from $174 to $29,610 in LMICs. The huge range 389 
of costs in both settings reflects the difficulty associated with accurately estimating the costs 390 
attributable to SSI and consequently limited cross-study comparability of findings. Five main 391 
challenges to the estimation of the costs are summarised below:  392 
1. Time horizon for capturing an SSI 393 
2. Choice of comparator 394 
3. Over reliance on single centre studies and small number of patients with SSI 395 
4. Under representation of Low Income and Lower Middle Income Countries in the 396 
literature 397 
5. Inconsistency in consideration of costs and narrow cost perspective.  398 
 399 
1. Time horizon and follow-up: Studies from both settings used the CDC criteria to define 400 
SSI, but the lack of follow-up in LMIC studies failed to meet the recommended time 401 
needed to detect an SSI. According to the CDC, the specified time horizon for an SSI to 402 
occur is up to 30 days post-surgery for non-implant operations and up to 12 months for 403 
implant operations. Where no follow-up exists, there is a risk of underestimating the true 404 
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number of SSI patients and skewing the cost burden information to only patients with an 405 
inpatient SSI. The type of follow-up method will affect the detection rate but this was 406 
rarely mentioned in studies. Inadequate IT infrastructure in LMIC healthcare systems has 407 
been implicated as the cause of poor follow up through health care pathways[68]. 408 
2. The choice of comparator was important in the estimating the additional cost burden of 409 
SSI. Most LMIC studies did not use any adjustments for potential confounders which 410 
risked producing a false estimation (overestimate or underestimate) of SSI costs due to an 411 
imbalance in the characteristics of the comparators. For example, some of the differences 412 
in costs between SSI patients and non-SSI patients could be due to greater levels of 413 
comorbidity in one group, causing a higher estimated additional cost for SSI than may 414 
otherwise be true. In contrast, the majority of the European studies did make adjustments 415 
for potential confounders but few gave justification for the included matching variables. 416 
Proper consideration of matching variables can help avoid the problem of undermatching 417 
or overmatching in case-control studies[25].  418 
3. Over reliance on single centre studies: Both settings had an overreliance on single 419 
centre studies and the lack of multi-centre settings affected the representativeness of the 420 
findings. Greater numbers of hospitals participating and more diversity in hospital 421 
settings for each study would help strengthen the applicability and robustness of any 422 
findings. Some studies with a patient population across multiple surgical categories 423 
indicated differential additional SSI costs by procedure. However, this was only reported 424 
in the European studies and there was no clear signal on which procedures would be the 425 
costliest across these studies. Some studies had low numbers of SSI patients; cost 426 
estimation with a small sample size are prone to unreliability and imprecision. This has an 427 
impact on the interpretation of the results given that the differences in costs between SSI 428 
patients and non-SSI patients could be driven by chance or extreme values. In general, the 429 
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European studies had more patients, but this could be as a result of better SSI 430 
surveillance.  431 
4. Lack of studies in Low Income and Lower Middle Income countries: The LMIC 432 
studies found in the review span across different continents, patient populations, surgical 433 
procedures, income levels, health systems and cultures. However, there was an 434 
underrepresentation of studies in Low Income countries and Lower Middle Income 435 
countries making the generalisability of the overall findings to these settings more 436 
difficult.  437 
5. Inconsistency in consideration of costs and narrow cost perspective: The type of costs 438 
included will have a direct impact on the estimation of SSI costs. The cross-country cost 439 
comparison of SSI was hindered by the absence of a standardized approach in the basket 440 
of cost items included. However, even when a standardized approach is adopted as in a 441 
multinational randomised control trial, costs and resource use will differ across 442 
countries[69]. Variations in clinical practice and relative prices across countries will 443 
affect the transferability of healthcare resource use and costs[70]. Despite an SSI has far-444 
reaching resource use implications for the healthcare system, patient and community, 445 
costs from the patient’s perspective were not considered in any LMIC study. The absence 446 
of patient and societal costs are concerning given the relatively high out of pocket 447 
expenditure faced by patients in LMICs. Lack of consideration of these costs is likely to 448 
underestimate the true cost burden of SSI, and one of the European studies found that the 449 
addition of informal care alone doubled the costs associated with SSI[41]. 450 
 451 
Strengths and weaknesses 452 
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The strength of this study is that it is the first systematic review to specifically investigate the 453 
economic impact of SSI in LMICs. By including a parallel review of SSI with HICs in 454 
Europe, the review offers new insight into the methodological considerations and the 455 
potential data gaps in SSI cost studies from the contrasting settings. 456 
A limitation relates to the use of an implied PPP exchange rate for some of the LMIC settings 457 
and the English language restriction for the article inclusion criteria. A PPP exchange rate is 458 
used to adjust for the cost of living differences between countries. Relying on implied PPP 459 
rates for adjusting the comparative cost results is likely to introduce measurement error in the 460 
study findings compared to those using official PPP rates[71]. A previous study looking at 461 
risk factors for child conduct problems and youth violence in LMICs reported that including 462 
only English language studies was likely to have reduced the number of potentially relevant 463 
articles by around 15%[72]. 464 
Comparison with other studies 465 
Previous systematic reviews have looked at the costs of a SSI, mainly in high income 466 
countries[5, 73, 74]. Similar issues were encountered on the lack of standardized approach, 467 
insufficient detail on how costs were derived, and the failure to include societal costs. To 468 
better articulate the first two study issues, the present review added the use of a cost of illness 469 
reporting checklist to give an indication of the study transparency and comparability. In 470 
contrast to the previous systematic reviews, the search criteria of the present study were not 471 
limited by date to be as inclusive as possible. A previous systematic review established that 472 
many essential surgical interventions are cost-effective in resource poor countries[75]. 473 
However, complications such as SSI can impose unforeseen additional costs in these 474 
countries, which are overlooked by most of the studies included in the paper. 475 
 476 
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 477 
Implications for practice 478 
An SSI is the most common hospital acquired infection in LMICs[76].Preventing SSIs will 479 
decrease the financial burden of both the patient and health system. Hospital bed 480 
overcrowding is problematic in LMICs[77-79] and any reduction in SSIs would help to 481 
increase capacity in bed days. 482 
There is need for multicentre studies with large number of SSI patients to capture relevant 483 
costs and consequences of the infection across settings. The use of a standardized data 484 
collection pathway will help improve cross-study comparability. Future studies should 485 
include more detailed information on analytic approaches in the methods along with rationale 486 
and discussion of their likely impact on results. Ideally, reporting should include resource 487 
use, costs and cost categories of SSI and non-SSI patients to give more context on the key 488 
influences for the cost difference between patient groups. The identification, measurement 489 
and collection of costs should as far as possible take a societal perspective to appropriately 490 
encompass all healthcare, patient and wider society costs that may be affected by an SSI. The 491 
costs of inpatient SSI and outpatient SSI need to be differentiated given that the former is 492 
plausibly more expensive from increased inpatient bed days. Subgroup analysis would allow 493 
the heterogeneity to be examined between these groups instead of being masked in overall 494 
figures.  495 
Conclusions 496 
An SSI represents a financial burden in both high income and LMICs settings. The 497 
magnitude of the cost difference depends on the SSI definition used, severity of SSI, patient 498 
population, choice of comparator, hospital setting, and cost items included. Huge 499 
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heterogeneity in design and lack of transparency has made it difficult to draw meaningful 500 
comparison across studies and countries. 501 
We suggest that future studies endeavour to achieve the most appropriate time horizon to 502 
include appropriate complications, focus on a comparator that has a degree of matching of 503 
patient characteristics, and researchers should limit their focus on single centre studies to 504 
increase generalisability. These three items are typically within the gift of researchers during 505 
the design stage. The impact of SSI in low-income countries is likely to be severe and more 506 
research in these setting is required with particular care on choosing the right perspective for 507 
the collection of cost data, which is key to ensuring the appropriate financial burden captured. 508 
Agreement on what would the composition of a standardised basket of items of costs to 509 
include would also be extremely helpful.  510 
 511 
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